Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline for neuroprotection after pediatric cardiac arrest
PACTR201907742119058Phase 4Completed
- Sponsor
- Faculty of Medicine, Tanta University
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypoxic-ischemic encephalopathy (HIE) and cardiac arrest (SCA) comparing Citicoline with Placebo (2 arms). Primary endpoint: Glasgow Coma Scale. Started May 2019; status: completed.
02
Drugs
citicoline
03
Conditions
hypoxic-ischemic encephalopathy (HIE)cardiac arrest (SCA)
Beyond the preview
Go deeper on PACTR201907742119058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201907742119058.